PerkinElmer Announces new Subsidiary to Distribute and Service Instrumentation in Ireland
News Apr 30, 2008
PerkinElmer Life and Analytical Sciences has announced that it will begin direct distribution of its instrumentation and extend its suite of services, including its portfolio of OneSource® solutions, in the Republic of Ireland and Northern Ireland.
The new PerkinElmer subsidiary, PerkinElmer Ireland Ltd., will assume direct responsibility for instrumentation sales, service and support for more than 250 customers in Ireland from its distributor, Foss Ireland Ltd.
PerkinElmer says that this move reinforces its commitment to provide its customers with many of the innovative products and services while providing a greater level of support for customers in a wide range of markets including pharmaceutical, biotech, and government and private research laboratories.
“Bringing a seamless product and service solution to our customers in Ireland will enable them to fully reap the benefit of PerkinElmer’s proven expertise globally to meet both scientific and business needs and improve laboratory performance,” said Robert F. Friel, President and Chief Executive Officer, PerkinElmer.
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019